Dietary Intervention for Low Free Sugars in Children With Non-alcoholic Fatty Liver Disease
1 other identifier
interventional
146
1 country
1
Brief Summary
A 48-week dietary intervention program was conducted in children aged 5-14 years with a diagnosis of NAFLD, who were randomized into a low free sugar diet group and a regular diet group. The primary objective of this study is to determine whether a low free sugar dietary intervention program improves liver function, fasting glucose, fasting insulin, lipid profile and hepatic steatosis in children with NAFLD. The effects of the intervention will be analyzed and compared at weeks 12, 24 and 48.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2022
CompletedFirst Submitted
Initial submission to the registry
August 21, 2024
CompletedFirst Posted
Study publicly available on registry
August 30, 2024
CompletedAugust 30, 2024
August 1, 2024
3.5 years
August 21, 2024
August 28, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
NAFLD
NAFLD was diagnosed using liver ultrasonography with a Phillip IU Elite color Doppler ultrasound after a fasting period to reduce gastrointestinal interference.
At weeks 1, 12 and 24
Dietary
The dietary habits of the subjects were evaluated by a semi-quantitative Food Frequency Questionnaire (FFQ), which was recalled over the past month and included food items, frequency, and amount of intake. The FFQ used in this study covered 72 food items from 11 food groups and 4 frequency categories, including 'average daily, weekly, monthly intake or hardly eat'.
At weeks 1, 12 and 24
Physical activity level
Physical Activity Questionnaire for Children (PAQ-C) was answered by subjects. The PAQ-C reflects the overall physical activity level of children in the past 7 days.The scale consists of 10 items, .and a 1-5 scale was used to obtain a total score by summing the scores of the individual items. The PAQ-C scale scores \< 2.33 defined as low physical activity levels, 2.33-3.66 as moderate physical activity levels, and \>3.66 as high physical activity levels.
At weeks 1, 12 and 24
Secondary Outcomes (6)
Height
At weeks 1, 12 and 24
Body weight
At weeks 1, 12 and 24
BMI
At weeks 1, 12 and 24
Waist circumference
At weeks 1, 12 and 24
Waist-to-height ratio
At weeks 1, 12 and 24
- +1 more secondary outcomes
Study Arms (2)
Intervention group
EXPERIMENTALControl group
NO INTERVENTIONInterventions
After baseline data collection, the intervention group received a 30-60 minute educational session with a dietitian and clinicians, including a health education prescription. Interventions occurred at weeks 1, 12 and 24, with routine evaluations of disease, diet, physical activity, and adherence. Follow-ups at 48 weeks assessed NAFLD extent, dietary profile, and health knowledge for both subjects and guardians.
Eligibility Criteria
You may qualify if:
- Age: above 5 years old and below 14 years old;
- Guardian's consent and signing of informed consent;
- WHO growth and development curves as the reference standard, overweight is defined as BMI greater than or equal to the 85th percentile of the WHO growth curves for children, and obesity is defined as BMI greater than or equal to the 95th percentile of the WHO growth curves for children;
- Liver imaging performance meets the diagnostic criteria of diffuse fatty liver.
You may not qualify if:
- Age \<5 years or \>14 years;
- Previous history of alcohol consumption;
- Non-cooperation with the study, inability to comply with the study treatment or study visit.
- Past or active hepatitis B virus infection;
- Past or active hepatitis C virus infection;
- Chronic or acute liver failure;
- Cholestasis;
- Hepatomegaly;
- Cystic fibrosis;
- α1-antitrypsin deficiency;
- Autoimmune hepatitis;
- Tyrosinemia;
- Galactosemia or any recognized liver disease, any physical condition deemed by a physician to be unable to complete the trial. Physical Condition.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
China Medical University
Shenyang, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Investigator
Study Record Dates
First Submitted
August 21, 2024
First Posted
August 30, 2024
Study Start
October 1, 2018
Primary Completion
April 1, 2022
Study Completion
April 1, 2022
Last Updated
August 30, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share